Patients with human leukocyte antigen (HLA)-B*15:02 and HLA-B*15:11 have an increased risk of SJS/TEN with carbamazepine use, especially in Asian populations [8-9]. This evidence concerns the gene HLA-B and Schwartz-Jampel syndrome.